High-risk (HR) neuroblastoma is characterized by V-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog (MYCN) amplification and segmental DNA copy number aberrations which are strongly correlated with poor prognosis, metastasis, and even treatment failure5–9. The gene discussed is MYCN; the disease is neuroblastoma.